1. Introduction {#s0005}
===============

Cystic echinococcosis (CE) is a zoonotic infection of humans and domestic animals, caused by the larval stages of the dog tapeworm *Echinococcus granulosus* ([@bb0035]). Dogs harbor the adults tape worm and human acquire the infection through accidental ingestion of parasite\'s eggs. The disease is prevalent in different parts of Iran, and human cases are regularly reported from different regions of the country ([@bb0010], [@bb0030], [@bb0040], [@bb0090], [@bb0115]). CE remains as one of the serious health problems in Iran and exerts heavy impact on the economy and social welfare of the people ([@bb0045]). Mean number of surgical CE cases per year for 2000--2009 in the country has been estimated at 1295 and the number of asymptomatic individuals living in the country estimated at 635,232 cases ([@bb0045]). The overall annual cost of CE, including both direct and indirect costs, in Iran has been estimated at US\$232.3 million ([@bb0045]).

The seroprevalence of CE varies in different geographical regions of the word, ranging from 1 to higher that 15% in different areas. Blood donors in Iran are usually healthy people who voluntarily donate blood just to help those in dreadful need of blood. The current study aimed to find out the seroprevalence of CE in a defined group, blood donors, in one of the largest provinces of Iran, Fars, in south part of the country.

2. Materials and methods {#s0010}
========================

2.1. Study area {#s0015}
---------------

This cross-sectional study was conducted in Fars province which is one of the thirty-one provinces of Iran and known as the cultural capital of the country. It is located in the south of the country and its administrative center is Shiraz ([Fig. 1](#f0005){ref-type="fig"}). It has an area of 122,400 km^2^. In 2011, this province had a population of 4.59 million people, of which 67.6% were registered as urban dwellers (urban/suburbs), 32.1% villagers (small town/rural), and 0.3% as nomad tribes.Fig. 1Map of Iran showing the location of Fars province.Fig. 1

2.2. Serum samples {#s0020}
------------------

After getting approval from the ethics committee of Shiraz University of Medical Sciences, blood samples were taken from a total of 1068 blood donors in five cities of Fars province of Iran (Darab, Firooz Abad, Kazeroon, Jahrom and Noor Abad) in 2013--2014 ([Fig. 2](#f0010){ref-type="fig"}). Samples were randomly collected from the subjects who donated the blood in blood service centers in each of five cities. Sera were stored at − 20 °C, until use. Sample size was valued based on the population of each city. Demographic characteristic of participants were noted during sample collection.Fig. 2Cities in Fars province, southern Iran, from where the serum samples were collected.Fig. 2

2.3. Preparation of antigen {#s0025}
---------------------------

Hydatid cyst fluid (HCF) was aspirated from hydatid cysts, obtained from livers of sheep slaughtered at the local abattoir. Antigen B (AgB) was purified and extracted from hydatid cyst fluid as previously described ([@bb0085], [@bb0075]). Briefly, 50 ml of HCF were dialyzed overnight against acetate buffer (5 mM, pH 5) at 4 °C. To remove the albumin, the sample was centrifuged at 50,000*g* for 30 min and the pellet was dissolved in 0.2 M phosphate buffer (pH 8). Saturated ammonium sulfate was used to eliminate the globulin from the sample. Lastly, the sample was boiled for 15 min and centrifuged at 50000*g* for 60 min to isolate antigen B from other antigens.

2.4. Antigen-B ELISA {#s0030}
--------------------

Sera samples were assessed for antibodies to hydatid cyst by antigen-B ELISA ([@bb0070]). Flat-bottom 96-well microplates (Nunc, Denmark) were coated, overnight, with 100 μl of AgB (5 μg/ml) in 0.05 M bicarbonate buffer, pH 9.6. Wells were washed three times in PBS plus 0.05% Tween 20 (PBS-T) and blocked with PBS-T containing 3% skimmed milk for 30 min at 37 °C. Sera were added, at 1:100 dilutions in PBST, and the plate was incubated at room temperature for 2 h. The plates were washed as before. Horseradish peroxidase (HRPO) conjugated anti-human antibodies (Sigma Chemical Co., Poole, Dorset, United Kingdom) was added, at 1: 4000 dilutions in PBS-T, and the microplate was incubated for 1 h and washed as before. The reaction was then developed in OPD substrate (5 mg o-phenylenediamine, 12.5 ml of 0.2 M citrate phosphate buffer pH 5, 10 μl of 30% H~2~O~2~). The absorbance was read at 492 nm after 30 min, using an automatic microplate reader (BIO-TEK®, ELx800, USA). The cut-off point was set as 3 SD above the mean of controls. Positive and negative controls were included in each run of ELISA.

3. Data analysis {#s0035}
================

All data were analyzed using SPSS software ver. 16 (Chicago, USA), using chi-squared and Fisher exact tests to compare the seroprevalence values relative to the features of the subjects. P value \< 0.05 was considered as significant.

4. Results {#s0040}
==========

Subjects of the study were 1008 males (94.4%) and 60 females (5.6%), from 5 cities of Fars province, including Darab, Firoozabad, Jahrom, Kazeroon and Noorabad. Of all the subjects, 327 cases were aged 21--30 years old and 304 cases were aged 31--40 years old. Anti-hydatid cyst antibodies were detected in 60 out of 1068 cases (5.6%).

Rate of seropositivity was 6.7% in females (4 cases out of 60 cases) and 5.5% in males (56 cases out of 1008 cases). The difference between sex and seropositivity to hydatid cyst was not statistically significant (P \> 0.05).

The highest rate of seropositivity to hydatid cyst in blood donors in this study was found in Firoozabad city while the lowest rate was found in Darab city. No statistically significant difference was found between seroprevalence rate in different cities (P \> 0.05). The highest rate of seropositivity was found in age group of higher than 50 years old ([Table 1](#t0005){ref-type="table"}).Table 1Seropositivity of hydatid cyst in blood donors in Fars province, southern Iran, based on the age of the participants.Table 1Age (year)Anti-hydatid cyst antibodies number (percent)PositiveNegativeTotal10--200 (0)20 (100)2021--3018 (5.5)309 (94.5)32731--4015 (4.9)289 (95.1)30441--5014 (5.4)245 (94.6)259\> 5012 (8.3)131 (91.7)143Total59 (5.6)994 (94.4)1053

Although different rates of seropositivity were seen in different age groups, yet the differences between the age groups and seropositivity to hydatid cyst were not statistically significant (P \> 0.05). Regarding the occupation of the subjects, most of them (46%) were self-employed, while 26% were employee, 7% were students, 5% were farmer and 16% were unemployed. No significant difference was found between occupation of the participants and seropositivity to hydatid cyst (P \> 0.05).

5. Discussion {#s0045}
=============

Human CE remains as a significant health problem in many of developing countries. The current study was done on 1068 blood donors in southern Iran. Since the target population of the study was blood donors, and in view of the fact that blood donors are mostly males and also are from specific age groups, therefor, the seroprevalence of CE reported in the study does not necessary shows the seroprevalence of hydatid cyst in the community. Most of these seropositive cases are asymptomatic individuals with hydatid cyst, but without apparent signs or symptoms. Blood donors may be infected by a few of parasitic diseases which may be transmitted to the recipient through transfusion ([@bb0095], [@bb0100]). However there is no risk of transmission of CE through blood transfusion.

According to data obtained in this study, the rate of seroprevalence in the studied population is 5.6%. Seroprevalence was assessed by an AgB-ELISA which is one of the most sensitive and specific test in serological diagnosis of CE ([@bb0070], [@bb0065], [@bb0055], [@bb0080]). Previous serological studies from various parts of the country showed different rate of seroprevalence ranged from 1 to more that 7% ([@bb0025], [@bb0030], [@bb0090], [@bb0120]).

Different serological studies have been done regarding the seroprevalence of CE in different geographical regions of the word ([@bb0005], [@bb0025]; [@bb0050], [@bb0060], [@bb0090], [@bb0105]).

Using antigen B-ELISA, same as the current study, a seroprevalence study in Khorram Abad, Iran, revealed anti-CE antibodies in 15.4% of the 617 participants ([@bb0120]). In Yousefi et al. study on 1000 blood donor in Chaharmahal and Bakhtiari Province, 33 out of 1000 (3.3%) of blood donors were seropositive for hydatid cyst ([@bb0110]). The rate of seroprevalence of CE in our study is almost similar to the rate of infection in other parts of Iran ([@bb0050], [@bb0110], [@bb0120]).

In a study in Turkey, anti-CE antibodies were investigated in the serum samples of CE suspected patients and the results showed that 439 out of 2921 cases (15.03%) were seropositive ([@bb0020]).

In our study no significant statistical difference was found between the rate of seropositivity to hydatid cyst in males and females. In Asghari et al. study in Arak, central Iran, the rate of CE in females was higher (3.99%) than males (2.26%), but again the differences were not statistically significant ([@bb0015]). Similarly in Yousefi et al. study in Chaharmahal and Bakhtiari Province, Iran, females had relatively higher rate of CE infection but the differences between males and females were not statistically significant ([@bb0110]).

Our study was done in five cities of Fars province. The rate of infection was almost similar in the five cities, which indicates that the disease is fairly prevalent throughout the province.

Taken together, findings of this study showed that CE, as an important zoonotic disease, is relatively prevalent throughout the Fars province in southern Iran. Some of these apparently healthy people may have tissue hydatid cyst, without having sign or symptoms.
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